| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/23/2003 | EP0831898B1 Modified meningococcal polysaccharide conjugate vaccines |
| 04/23/2003 | EP0817858B1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 04/23/2003 | EP0714439B1 Recombinant humanized anti-human immunodeficiency virus antibody |
| 04/23/2003 | EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor |
| 04/23/2003 | EP0550599B1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 04/23/2003 | CN1413258A Invasive bacterial vectors for expressing alphavirus replicons |
| 04/23/2003 | CN1413249A Human heparanase-related polypeptide and nucleic acid |
| 04/23/2003 | CN1413230A Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/23/2003 | CN1413220A Anti-prostate stem cell antigen (PSCA) antibody compositions and method of use |
| 04/23/2003 | CN1413219A Molecular structure of RHD negative genes locus |
| 04/23/2003 | CN1413118A Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof |
| 04/23/2003 | CN1412303A Recombinant gland related virus expressing human kallikrein, its preparation method and application |
| 04/23/2003 | CN1412201A Monoclonal antibody for resisting human liver cancer and its application |
| 04/23/2003 | CN1106247C Folding pocket knife with lock |
| 04/23/2003 | CN1106203C Chlamydia vaccine and process |
| 04/23/2003 | CN1106202C Anti-aids immunomodulator complex |
| 04/22/2003 | US6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof |
| 04/22/2003 | US6552172 Forming water in oil emulsion of fibrinogen, thrombin and factor XIII, homogenizing and isolating |
| 04/22/2003 | US6552164 Reagents and methods useful for detecting diseases of the breast |
| 04/22/2003 | US6552004 Delivery system for entrapping charged macromolecules and a method for preparing same |
| 04/22/2003 | US6551989 Preventing airway mucus production by administration of EGF-R antagonists |
| 04/22/2003 | US6551824 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318 |
| 04/22/2003 | US6551822 NL4 tie ligand homologue |
| 04/22/2003 | US6551820 Transgenic plants capable of expressing immunogenic polypeptides, including hepatitis B antigen (HBsAg) in quantities sufficient to elicit an immune response in a human or animal that consumes all or a part of the plant |
| 04/22/2003 | US6551810 Polypeptide retains the ability to dephosphorylate an activated MAP-kinase |
| 04/22/2003 | US6551808 Desaturase antigen of Mycobacterium tuberculosis |
| 04/22/2003 | US6551799 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 04/22/2003 | US6551773 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 04/22/2003 | US6551632 Methods and compositions for treating inflammatory bowel disease |
| 04/22/2003 | US6551600 Immunological adjuvant compounds compositions and methods of use thereof |
| 04/22/2003 | US6551598 Veterinary medicine |
| 04/22/2003 | US6551596 Fractions of Chlorella extract containing polysaccharide having immunomodulating properties |
| 04/22/2003 | US6551594 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
| 04/22/2003 | US6551592 Bind at the same time to the T-cell receptor complex, to tumour- associated antigens on a tumour cell, and, via the Fc portion of the bispecific antibody |
| 04/22/2003 | US6551588 Administering at or around the solid tumor an expressible nucleic acid encoding interleukin-3, and providing a tumor antigen, then treating the tumor with radiotherapy |
| 04/22/2003 | US6551587 Tissue-specific taanscriptional regulatory sequence operably linked to the coding region of a gene that is essential for replication of said vector. |
| 04/22/2003 | US6551586 Merozoite surface antigen1 (MSA1); vaccinia virus expression vector which expresses a malaria MSA1 peptide in combination with a signal peptide and anchor peptide in a host animal |
| 04/22/2003 | US6551585 Use of tumor necrosis factor as an adjuvant |
| 04/22/2003 | CA2253636C Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/22/2003 | CA2207741C Variants of human papilloma virus antigens |
| 04/22/2003 | CA2102623C Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
| 04/22/2003 | CA2098295C G protein-coupled glutamate receptors |
| 04/22/2003 | CA2096975C Cell stress transcriptional factors |
| 04/22/2003 | CA2091678C Viral defective vaccine produced by transcomplementing cell line |
| 04/18/2003 | WO2002030457A2 Microbes having an attenuating mutation comprising a transcription terminator |
| 04/18/2003 | CA2463482A1 Microbes having an attenuating mutation comprising a transcription terminator |
| 04/17/2003 | WO2003031942A1 Reagents and methods useful for detecting diseases of the breast |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003031930A2 A phosphatase associated with metastasis |
| 04/17/2003 | WO2003031599A2 Live attenuated salmonella strains for producing vaccines |
| 04/17/2003 | WO2003031595A2 Molecules for disease detection and treatment |
| 04/17/2003 | WO2003031588A2 Hepatitis c virus vaccine |
| 04/17/2003 | WO2003031578A2 Mammalian c-type lectins |
| 04/17/2003 | WO2003031569A2 Nucleic acid vaccines using tumor antigen encoding nucleic acids with cytokine adjuvant encoding nucleic acid |
| 04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
| 04/17/2003 | WO2003031477A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 04/17/2003 | WO2003031476A1 Antibody of human origin for inhibiting thrombocytes aggregation |
| 04/17/2003 | WO2003031475A2 Antibodies against kdr, their production and uses |
| 04/17/2003 | WO2003031473A1 Leukocyte inactivation module |
| 04/17/2003 | WO2003031471A1 Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb) |
| 04/17/2003 | WO2003031466A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/17/2003 | WO2003031464A2 Remodeling and glycoconjugation of peptides |
| 04/17/2003 | WO2003031462A2 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | WO2003030965A2 Artificial lymph node |
| 04/17/2003 | WO2003030935A2 Adjuvants for nucleic acid vaccines |
| 04/17/2003 | WO2003030934A2 Cpg formulations and related methods |
| 04/17/2003 | WO2003030933A1 Recombinant rabies vaccine and methods of preparation and use |
| 04/17/2003 | WO2003030932A1 Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use |
| 04/17/2003 | WO2003030931A2 Vaccine against arthropod-borne infectious diseases |
| 04/17/2003 | WO2003030922A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 04/17/2003 | WO2003030910A1 Pharmaceutical composition for the treatment of disorders of non-human mammals |
| 04/17/2003 | WO2003030833A2 Angiopoietin-2 specific binding agents |
| 04/17/2003 | WO2003030831A2 Treatment of prostate cancer by inhibitors of atp synthase |
| 04/17/2003 | WO2003030635A1 A herbal hepatoprotective and weight gain promoter and a process thereof |
| 04/17/2003 | WO2003030624A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/17/2003 | WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 04/17/2003 | WO2002094863A3 INTERFERON-α INDUCED GENE |
| 04/17/2003 | WO2002094325A3 Cytotoxic cd44 antibody immunoconjugates |
| 04/17/2003 | WO2002083727A3 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 04/17/2003 | WO2002083072A3 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 04/17/2003 | WO2002081706A3 Regulation of human phosphatase-like protein |
| 04/17/2003 | WO2002076486A3 Histidine-rich glycoprotein |
| 04/17/2003 | WO2002072636A3 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 04/17/2003 | WO2002072622A3 Vaccine antigens against infection by chlamydia trachomatis |
| 04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/17/2003 | WO2002061070A3 Environmentally regulated genes, involved in the virulence of streptococcus suis |
| 04/17/2003 | WO2002051237A9 Helicobacter proteins, nucleic acids and uses thereof |
| 04/17/2003 | WO2002050284A3 Oxidoreductases |
| 04/17/2003 | WO2002032445A3 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof |
| 04/17/2003 | WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 04/17/2003 | WO2002018576A3 Compositions and methods relating to lung specific genes |
| 04/17/2003 | WO2002018445A3 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 04/17/2003 | WO2002012341A3 Her-2/neu fusion proteins |
| 04/17/2003 | WO2002010402A3 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 04/17/2003 | WO2001085210A3 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 04/17/2003 | WO2001072773A3 Genes isolated from dendritic cells, gene products and methods employing the same |
| 04/17/2003 | US20030074678 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 04/17/2003 | US20030074676 I0nduction of preferential immunoglobulin in mammal; obtain mammal, immunize with tumor necrosis factor, monitor expression of immunoglobulin in milk |
| 04/17/2003 | US20030074142 Coincidence detection programmed media and system |